Collaborations & Alliances

H&T Presspart, Hovione Technology Enter DPI Pact

Provides access to Hovione’s API formulation and manufacturing services for new capsule-based dry powder inhaler

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

H&T Presspart, a manufacturer of components for metered dose inhalers (MDIs), has entered a collaboration with Hovione Technology to support a strategic plan to expand its portfolio of novel drug delivery systems in respiratory care. H&T Presspart has acquired the global rights to manufacture and commercialize a capsule-based dry powder inhaler (DPI) developed by Hovione. H&T Presspart released an enhanced version of the DPI, which will be marketed as PowdAir Plus.    PowdAir Plus ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters